Incidence of pulmonary disease caused by mycobacteria other than tuberculosis in British Columbia

Canadian Respiratory Journal

Volumn 9, Issue 5, 2002, Pages 319-323

  Elwood, R Kevin ^a   Opaso Saez, Anabelle M ^b   Lentini, Vittorio ^c   Shadmani, Ramak ^a  

^a Div of Tuberculosis Control   (Canada)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF NATIONAL DEFENCE   (Canada)

Author keywords

Incidence rate; Mycobacteria infection other than tuberculosis

Indexed keywords

CLOFAZIMINE; ISONIAZID; LIVER ENZYME; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ABORIGINE; ADULT; AGE DISTRIBUTION; ARTICLE; ASIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIRTH; BLOOD CELL COUNT; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DRUG HYPERSENSITIVITY; ETHNIC GROUP; FEMALE; FEVER; HUMAN; INCIDENCE; INDUSTRIALIZATION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NAUSEA AND VOMITING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; SIDE EFFECT; SPUTUM SMEAR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; VISUAL IMPAIRMENT;

EID: 0036759890     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/202870     Document Type: Article

References (19)

1. Rosenwig DY. Pulmonary mycobacterial infection due to mycobacterium intracellulare-avium complex: clinical features and course in 100 consecutive cases. Chest 1979;75:115-9.
2. O'Brien RJ, Geiter LJ, Synder DE. The epidemiology of non-tuberculous mycobacterium in the United States. Am Rev Respir Dis 1997;135:1007-14.
3. Tanaka E, Kimoto T, Matsumoto H, et al. Familial pulmonary Mycobacterium avium complex disease. Am J Respir Crit Care Med 2000;161:1643-7.
4. Takahashi M, Ishizaka A, Nakamura H, et al. Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 2000;162:316-8.
5. Kubo K, Yamazaki Y, Hanaoka M, et al. Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 2000;161:1368-71.
6. Prince DS, Huston DD, Steiner RN, et al. Infection of Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
7. Kubo KY, Yamazaki T, Hachiya M, Hoyasaka T, Honda M, Hasegawa Sone S. Mycobacterium avium-intracelulare infection in patients without known pre-disposing lung disease. Lung 1998;176:381-9.
8. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:1-25S.
9. O'Brien RJ, Geiter OJ, Snider DE. Epidemiology of non-tuberculosis mycobacterial diseases in the United States. Result of a National Survey. Am Rev Respir Dis 1987;135:1007-14.
10. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease. Incidence, presentation and response to therapy in a community setting. Am Rev Respir Dis 1991;143:1381-5.
11. Isaac-Renton JL, Allen EA, Chao CW, Grzybowski S, Wittaker EI, Black WA. Isolation and geographic distribution of mycobacteria other than M tuberculosis in British Columbia 1972-1981. CMAJ 1985;133:573-609.
12. Al-Momari MS, Black W, Elwood K. Pulmonary disease due to Mycobacterium malmoense in British Columbia. Can Respir J 1998;5:135,8.
13. Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbial Rev 1996;9:177-215.
14. Kennedy TP, Webber DJ. Non-tuberculous mycobacteria: an under appreciated cause of geriatric lung disease. Am J Respir Crit Care Med 1994;149:1654-8.
15. Swensen SJ, Hartman TE, Williams DE. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 1994;105:49-52.
16. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis, thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991;144:914-6.
17. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 1994;75:348-52.
18. Fujita J, Ohtsuki Y, Suemitsu I, et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium-intracellulare complex disease. Eur Respir J 1999;13:532-40.
19. Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium-intracellulare, M malmoense and M xenopi in HIV negative patients: rifampin, ethambutol and isoniazid versus rifampin and ethambutol. Thorax 2001;56:167-72.